MCIA Inc Purchases 363 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

MCIA Inc lifted its position in UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 11.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 3,619 shares of the healthcare conglomerate’s stock after buying an additional 363 shares during the period. MCIA Inc’s holdings in UnitedHealth Group were worth $1,759,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently made changes to their positions in UNH. TimeScale Financial Inc. lifted its stake in shares of UnitedHealth Group by 276.9% in the third quarter. TimeScale Financial Inc. now owns 49 shares of the healthcare conglomerate’s stock worth $25,000 after buying an additional 36 shares in the last quarter. Pflug Koory LLC raised its holdings in shares of UnitedHealth Group by 160.0% during the third quarter. Pflug Koory LLC now owns 52 shares of the healthcare conglomerate’s stock valued at $26,000 after purchasing an additional 32 shares during the last quarter. Belmont Capital LLC raised its holdings in shares of UnitedHealth Group by 294.1% during the third quarter. Belmont Capital LLC now owns 67 shares of the healthcare conglomerate’s stock valued at $34,000 after purchasing an additional 50 shares during the last quarter. O Dell Group LLC raised its holdings in shares of UnitedHealth Group by 76.9% during the third quarter. O Dell Group LLC now owns 69 shares of the healthcare conglomerate’s stock valued at $35,000 after purchasing an additional 30 shares during the last quarter. Finally, Legend Financial Advisors Inc. purchased a new position in shares of UnitedHealth Group during the third quarter valued at approximately $37,000. Institutional investors own 86.31% of the company’s stock.

UnitedHealth Group Price Performance

Shares of NYSE:UNH traded down $2.52 during midday trading on Friday, reaching $469.50. 5,289,996 shares of the company were exchanged, compared to its average volume of 3,713,042. The company has a current ratio of 0.77, a quick ratio of 0.77 and a debt-to-equity ratio of 0.67. The business’s fifty day moving average is $483.26 and its two-hundred day moving average is $510.78. UnitedHealth Group Incorporated has a one year low of $449.70 and a one year high of $558.10. The stock has a market cap of $437.97 billion, a PE ratio of 22.16, a price-to-earnings-growth ratio of 1.30 and a beta of 0.69.

UnitedHealth Group (NYSE:UNH – Get Rating) last issued its earnings results on Friday, January 13th. The healthcare conglomerate reported $5.34 earnings per share for the quarter, topping analysts’ consensus estimates of $5.17 by $0.17. UnitedHealth Group had a net margin of 6.21% and a return on equity of 27.04%. The firm had revenue of $82.79 billion during the quarter, compared to analyst estimates of $82.53 billion. During the same quarter in the prior year, the business earned $4.48 earnings per share. UnitedHealth Group’s revenue for the quarter was up 12.3% on a year-over-year basis. As a group, analysts predict that UnitedHealth Group Incorporated will post 24.91 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 21st. Shareholders of record on Monday, March 13th will be given a dividend of $1.65 per share. The ex-dividend date of this dividend is Friday, March 10th. This represents a $6.60 annualized dividend and a yield of 1.41%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 31.15%.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on UNH. Raymond James cut shares of UnitedHealth Group from a “strong-buy” rating to an “outperform” rating and set a $615.00 price objective for the company. in a report on Monday, November 21st. Stephens reaffirmed an “overweight” rating and set a $605.00 target price on shares of UnitedHealth Group in a report on Tuesday, February 28th. StockNews.com raised shares of UnitedHealth Group from a “buy” rating to a “strong-buy” rating in a report on Saturday, March 11th. Deutsche Bank Aktiengesellschaft upped their target price on shares of UnitedHealth Group from $615.00 to $617.00 and gave the company a “buy” rating in a report on Tuesday, January 24th. Finally, UBS Group reduced their target price on shares of UnitedHealth Group from $590.00 to $550.00 and set a “neutral” rating for the company in a report on Wednesday, January 18th. Three equities research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus price target of $599.68.

UnitedHealth Group Company Profile

(Get Rating)

UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.